Emerging Markets Monthly Highlights: Faster Vaccination Pace Still Not Sufficient to Beat The Pandemic - S&P Global Ratings’ Credit Research

Emerging Markets Monthly Highlights: Faster Vaccination Pace Still Not Sufficient to Beat The Pandemic

Emerging Markets Monthly Highlights: Faster Vaccination Pace Still Not Sufficient to Beat The Pandemic - S&P Global Ratings’ Credit Research
Emerging Markets Monthly Highlights: Faster Vaccination Pace Still Not Sufficient to Beat The Pandemic
Published Jul 15, 2021
Published Jul 15, 2021
Price US$ 600.00  |  Buy this Report Now

About This Report

  
Abstract:

We have increased our 2021 GDP growth projections for most major emerging markets (EM), as the economic impact of pandemic-related restrictions becomes less severe. GDP data for Q1 is clear evidence of this trend, surprising to the upside in several EMs, mainly due to stronger-than-expected domestic demand, and in many cases, activity in services, even as new daily COVID-19 cases reached new record highs at that time in some countries. However, the risks to our economic outlook for EMs are skewed to the downside and have risen in recent weeks as a new COVID-19 wave takes hold in several countries, mostly due to the Delta variant. In some EMs, new daily virus cases have reached new highs, prompting some governments to reimpose lockdown measures. Even if the impact of lockdowns on activity has lessened, the on-and-off measures act as a drag on the economic recovery. In the absence of a faster vaccination pace, the exit from the pandemic-related downturn could be delayed for several EMs.

  
Report Type:

Commentary

Ticker
1179Z@TB
Issuer
Sector
Global Issuers, Structured Finance
Country
Region
Latin America
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Emerging Markets Monthly Highlights: Faster Vaccination Pace Still Not Sufficient to Beat The Pandemic" Jul 15, 2021. Alacra Store. Nov 07, 2026. <http://www.alacrastore.com/s-and-p-credit-research/Emerging-Markets-Monthly-Highlights-Faster-Vaccination-Pace-Still-Not-Sufficient-to-Beat-The-Pandemic-2713073>
  
APA:
S&P Global Ratings’ Credit Research. (). Emerging Markets Monthly Highlights: Faster Vaccination Pace Still Not Sufficient to Beat The Pandemic Jul 15, 2021. New York, NY: Alacra Store. Retrieved Nov 07, 2026 from <http://www.alacrastore.com/s-and-p-credit-research/Emerging-Markets-Monthly-Highlights-Faster-Vaccination-Pace-Still-Not-Sufficient-to-Beat-The-Pandemic-2713073>
  
US$ 600.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Residential Mortgage-Backed Securities from one place.